Comparisons of the durability of 6 months versus 12 months antiviral therapy for hepatitis B after end of chemotherapy
Not Applicable
Completed
- Conditions
- Hepatitis B in patients with cancer after completion of immunosuppressive anticancer therapyInfections and Infestations
- Registration Number
- ISRCTN17868223
- Lead Sponsor
- Kaohsiung Chang Gung Memorial Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 61
Inclusion Criteria
1. Over 20 years old
2. Hepatitis B surface antigen (HBsAg) seropositive for >6 months
3. Cancer patients receiving chemotherapy
Exclusion Criteria
Patients who had co-infection with human immunodeficiency virus, hepatitis C virus or hepatitis D virus by serological assays
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method